20.40
16.91%
2.95
Handel nachbörslich:
21.99
1.59
+7.79%
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
51.87%
8.463
|
17.58 | 12.72 | 7.497 | 26.11 |
Operating Expenses
|
9.90%
19.15
|
21.26 | 22.21 | 21.59 | 23.33 |
Benefits Costs and Expenses |
100.00%
-
|
20.73 | 21.59 | 20.97 | - |
Costs And Expenses |
7.61%
19.15
|
20.73 | 21.59 | 20.97 | 23.33 |
Depreciation and Amortization |
9.09%
0.036
|
0.033 | 0.022 | 0.025 | 0.032 |
Operating Income/Loss |
190.83%
-10.69
|
-3.676 | -9.49 | -14.10 | 2.781 |
Income/Loss From Continuing Operations Before Tax |
368.75%
8.463
|
-3.149 | -8.877 | -13.47 | 26.11 |
Income Tax Expense/Benefit |
100.00%
-
|
0.064 | 0.23 | 0.149 | - |
Income/Loss From Continuing Operations After Tax |
221.38%
-10.33
|
-3.213 | -9.107 | -13.62 | 3.013 |
Net Income/Loss
|
221.38%
-10.33
|
-3.213 | -9.107 | -13.62 | 3.013 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 0.636 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
337.59%
4.5378
|
1.037 | 90.29 | 90.12 | 78.64 |
Diluted Average Shares |
337.59%
4.5378
|
1.037 | 90.29 | 90.12 | 101.19 |
Basic Earnings Per Share |
7,500%
-2.28
|
-0.03 | -0.10 | -0.15 | 0.03 |
Diluted Earnings Per Share |
7,500%
-2.28
|
-0.03 | -0.10 | -0.15 | 0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | 0.677 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):